Company
United StatesPublic company, NASDAQ: OSUROraSure Technologies, Inc. (NASDAQ: OSUR), Bethlehem, PA – FDA Inspections
Inspection records and compliance data for OraSure Technologies, Inc. in Bethlehem, Pennsylvania. 3 FDA inspections on record, last inspected March 09, 2018. Publicly traded as NASDAQ: OSUR.
Company Profile
This profile covers OraSure Technologies, Inc. based in Bethlehem, Pennsylvania, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 1
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected May 24, 2012. Last inspected March 9, 2018.
Most cited issue areas
- Report of Death or Serious Injury1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 9, 2018 | NAI | Biologics · Blood and Blood Products | 1046324 |
| August 25, 2015 | VAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 939374 |
| May 24, 2012 | NAI | Medical Devices & Rad Health · Compliance: Devices | 777546 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
OraSure Technologies, Inc.
Stock ticker
OSUR
Exchange
NASDAQ
Share price
$3.62
Market cap
$250.0M
Price as of
November 13, 2026
FEI Number
3003297763
Address
150 Webster St, Bethlehem, Pennsylvania 18015, United States
Country
United States
ID: c4c3764e-2ed9-4254-8e33-104f1e784671